Connect with us

Business

Pharmacy business rates rise puts hundreds at closure risk

Published

on

Pharmacy business rates rise puts hundreds at closure risk

Hundreds of pharmacies are facing closure because of soaring business rates, with owners warning that high taxes are forcing them to cut services for vulnerable patients.

Almost half of the 420 pharmacy owners surveyed by the National Pharmacy Association (NPA) said they were considering shutting down their practices because of higher business rates bills. The trade body found 55 per cent were considering moving to cheaper premises, raising fears that some rural and coastal communities could be left without a local branch.

Pharmacies, many of which are family-run businesses, are unable to offset the higher tax burden by raising prices, which are fixed by the NHS. Roughly 90 per cent of pharmacies’ income comes from the health service, the NPA said, leaving owners with no commercial lever to pull when fixed costs rise.

Prime Minister Andy Burnham has made lowering business rates for high-street businesses a key pillar of his summer policy blitz, announcing a 20 per cent reduction for pubs, clubs and live music venues from April next year. Pharmacies have been excluded from the relief.

The tax squeeze has intensified since business rates were increased for many properties after Rachel Reeves’s second Budget. Bills have also been affected by the latest revaluation of commercial property, which fed new rateable values into bills from April. GPs and NHS dentists, meanwhile, have their business rates reimbursed.

Advertisement

Onkar Singh, who runs 20 pharmacies across the Black Country, Staffordshire, Herefordshire and Worcestershire, has seen his business rates bill rise by roughly 20 to 30 per cent in the past year. His total bill is now about £250,000.

He has closed two of his pharmacies in the past two years and reduced opening hours across virtually his entire estate. He has also been forced to cut back services, such as offering free medicine deliveries to elderly patients.

Singh said: “The last three years have been the worst period in my 30 years of pharmacy.

“People are having to close a lifetime’s worth of work and effort, and having to close or reduce hours or dip into their pension pot just to keep going for their communities.”

Advertisement

The NPA survey found that 92 per cent of pharmacies said their rates bill was preventing them from investing in their workforce or renovations. Some pharmacists have warned that their bills have tripled, echoing the anger among small firms over the revaluation that prompted thousands to write to the then chancellor.

Singh said the impact was particularly painful because pharmacies were often being asked to fill gaps elsewhere in the NHS.

He said: “It is frustrating that pubs and restaurants get the headlines, but pharmacies are actually delivering care.

“The NHS accepted that pharmacy did an exceptional job, but in terms of funding and support with business rates we seem to be forgotten.”

Advertisement

The NPA said 44 pharmacies had already closed this year, leaving the national network at its smallest since 2006. Nine in 10 council areas have lost at least one pharmacy since 2022.

Olivier Picard, the chairman of the trade group, said pharmacies should receive the same rates treatment as GPs and dentists, arguing that they provide an essential health service.

A government spokesperson said: “Pharmacies already benefit from our wider business rates reforms, including permanently lower multipliers and our £4.3bn package to support ratepayers, and the government has increased funding for the sector by £340m this year as part of our shift to bring care closer to home.”

For owners of other high-street businesses, the pharmacy case is a reminder that rates relief is being targeted sector by sector, as with the £150m package for town centres that business leaders dismissed as a sticking plaster, rather than applied across the board. Firms whose prices are set by a third party, whether that is the NHS, a franchisor or a long-term contract, have no way of passing the increase on, and the NPA’s finding that 92 per cent of pharmacies have shelved investment shows where the money goes instead.

Advertisement

Jamie Young

Jamie Young

Jamie Young is Senior Reporter at Business Matters, covering SME finance, employment law and Westminster policy since 2016. He has reported on every Budget and Autumn Statement since 2018, helped make sense of the ‘covid era’ and the bounce-back loan scheme from launch through the fraud investigations, and broke the magazine’s coverage of the 2024 late-payment reforms. He joined Business Matters straight from completing his BA in Administration from Exeter University and is NCTJ-qualified. Reach him at jyoung@cbmeg.co.uk

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Canada to impose retaliatory tariffs across a raft of US sectors, Carney says

Published

on


Canada to impose retaliatory tariffs across a raft of US sectors, Carney says

Continue Reading

Business

Iran condemns US plans to announce new sanctions

Published

on


Iran condemns US plans to announce new sanctions

Continue Reading

Business

Monthly market brief: equities, bonds, crypto, and commodities in August 2026

Published

on


Monthly market brief: equities, bonds, crypto, and commodities in August 2026

Continue Reading

Business

Will Apple’s risk appetite change under John Ternus?

Published

on


Will Apple’s risk appetite change under John Ternus?

Continue Reading

Business

Russian ’double-tap’ strike on shopping centre in Ukraine kills 16 and wounds 130

Published

on


Russian ’double-tap’ strike on shopping centre in Ukraine kills 16 and wounds 130

Continue Reading

Business

Canada to match U.S. tariffs dollar for dollar after trade talks collapse

Published

on


Canada to match U.S. tariffs dollar for dollar after trade talks collapse

Continue Reading

Business

Buy 4 Barron's Better Bets (Than T-Bills) Out Of 11 'Safer' August DiviDogs

Published

on

Buy 4 Barron's Better Bets (Than T-Bills) Out Of 11 'Safer' August DiviDogs

Buy 4 Barron's Better Bets (Than T-Bills) Out Of 11 'Safer' August DiviDogs

Continue Reading

Business

Principal Well-Being Index: More AI Optimism Amid Existing Labor Pressures

Published

on

Principal Well-Being Index: More AI Optimism Amid Existing Labor Pressures

The Principal Financial Group (The Principal®) is a global investment management leader offering retirement services, insurance solutions and asset management. The Principal offers businesses, individuals and institutional clients a wide range of financial products and services, including retirement, asset management and insurance through its diverse family of financial services companies. Founded in 1879 and a member of the FORTUNE 500®, the Principal Financial Group has $519.3 billion in assets under management1 and serves some 19.7 million customers worldwide from offices in Asia, Australia, Europe, Latin America and the United States. Principal Financial Group, Inc. is traded on the New York Stock Exchange under the ticker symbol PFG. For more information, visit www.principal.com.
Insurance products issued by Principal National Life Insurance Co (except in NY) and Principal Life Insurance Co. Plan administrative services offered by Principal Life. Principal Funds, Inc. is distributed by Principal Funds Distributor, Inc. Securities offered through Princor Financial Services Corp., 800/247-1737, Member SIPC and/or independent broker/dealers. Principal National, Principal Life, Principal Funds Distributor, Inc. and Princor® are members of the Principal Financial Group®, Des Moines, IA 50392.
Investing involves market risk, including possible loss of principal.

Continue Reading

Business

Putin says Ukraine opened ’Pandora’s box’ with strikes on economic targets

Published

on


Putin says Ukraine opened ’Pandora’s box’ with strikes on economic targets

Continue Reading

Business

Choosing Between Semis And SaaS, You May Not Need To (NYSEARCA:SPY)

Published

on

Choosing Between Semis And SaaS, You May Not Need To (NYSEARCA:SPY)

This article was written by

A seasoned consulting specialist at a leading Central Asian bank. The author behind Novo Capital brings half a decade of experience delivering strategic insight and analysis for the bank’s clientele within the private banking branch. Launching the career back in 2020 after graduating from a top CA university, the author developed a resilient methodology forged amidst global market volatility, focusing on corporate valuation, due diligence for investment opportunities, and crafting spot-on forecasts that guide long-term investment strategy. The goal of contributing to Seeking Alpha seems to be quite simple: ideas are worth discussing, and one can gain “alpha” only through gaining out-of-consensus information from opinions few professionals have nowadays. That’s exactly the reason Novo Capital was created.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of SPY, NDX, XLK, SMH, IGV either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Trending

Copyright © 2025